Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial ; volume:22 ; number:1 ; day:7 ; month:3 ; year:2024 ; pages:1-10 ; date:12.2024
BMC medicine ; 22, Heft 1 (7.3.2024), 1-10, 12.2024

Creator
Liu, Yanfei
Ping, Lingyan
Song, Yuqin
Tang, Yongjing
Zheng, Wen
Liu, Weiping
Ying, Zhitao
Zhang, Chen
Wu, Meng
Feng, Feier
Lin, Ningjing
Tu, Meifeng
Zhu, Jun
Xie, Yan
Contributor
SpringerLink (Online service)

DOI
10.1186/s12916-024-03329-8
URN
urn:nbn:de:101:1-2405102103519.997582097190
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Liu, Yanfei
  • Ping, Lingyan
  • Song, Yuqin
  • Tang, Yongjing
  • Zheng, Wen
  • Liu, Weiping
  • Ying, Zhitao
  • Zhang, Chen
  • Wu, Meng
  • Feng, Feier
  • Lin, Ningjing
  • Tu, Meifeng
  • Zhu, Jun
  • Xie, Yan
  • SpringerLink (Online service)

Other Objects (12)